The underutilization of cardiac medications of proven benefit, 1990 to 2002 (Q28194871)

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Medical treatment for stroke prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Antithrombotic therapy in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Variations in family physicians' and cardiologists' care for patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Cumulative meta-analysis of therapeutic trials for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Aspirin in the treatment and prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

National patterns and predictors of beta-blocker use in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Aspirin use is low among United States outpatients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

National Patterns of Medication Treatment for Depression, 1987 to 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Pharmacotherapy for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Physician use of beta-adrenergic blocking therapy: a changing perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021

Why don't physicians follow clinical practice guidelines? A framework for improvement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902670-0

7 January 2021